UK markets close in 3 hours 56 minutes

IDEXX Laboratories, Inc. (IDXX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
487.07+3.39 (+0.70%)
At close: 04:00PM EDT
486.10 -0.97 (-0.20%)
After hours: 06:21PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 40.23B
Enterprise value 40.90B
Trailing P/E 47.20
Forward P/E 44.64
PEG ratio (5-yr expected) 4.65
Price/sales (ttm)10.98
Price/book (mrq)25.64
Enterprise value/revenue 10.98
Enterprise value/EBITDA 32.93

Trading information

Stock price history

Beta (5Y monthly) 1.27
52-week change 30.07%
S&P500 52-week change 325.59%
52-week high 3583.39
52-week low 3372.50
50-day moving average 3518.55
200-day moving average 3501.61

Share statistics

Avg vol (3-month) 3422.64k
Avg vol (10-day) 3541.25k
Shares outstanding 582.59M
Implied shares outstanding 682.59M
Float 881.68M
% held by insiders 10.93%
% held by institutions 192.70%
Shares short (15 Apr 2024) 41.71M
Short ratio (15 Apr 2024) 44.26
Short % of float (15 Apr 2024) 42.65%
Short % of shares outstanding (15 Apr 2024) 42.07%
Shares short (prior month 15 Mar 2024) 41.8M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 316 Jun 2015

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 23.26%
Operating margin (ttm)31.01%

Management effectiveness

Return on assets (ttm)22.63%
Return on equity (ttm)71.91%

Income statement

Revenue (ttm)3.72B
Revenue per share (ttm)44.83
Quarterly revenue growth (yoy)7.10%
Gross profit (ttm)N/A
EBITDA 1.23B
Net income avi to common (ttm)866.57M
Diluted EPS (ttm)10.33
Quarterly earnings growth (yoy)10.10%

Balance sheet

Total cash (mrq)397.43M
Total cash per share (mrq)4.81
Total debt (mrq)1.07B
Total debt/equity (mrq)68.13%
Current ratio (mrq)1.57
Book value per share (mrq)18.93

Cash flow statement

Operating cash flow (ttm)921.18M
Levered free cash flow (ttm)733.09M